Market Overview:
The global continuous glucose monitoring system for elderly market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of diabetes, technological advancements in continuous glucose monitoring systems, and rising demand for homecare settings. Based on type, the global continuous glucose monitoring system for elderly market can be segmented into wearable and implantable devices. The implantable devices segment is expected to grow at a higher CAGR than the wearable devices segment during the forecast period from 2018 to 2030. This growth can be attributed to factors such as increasing preference for minimally invasive procedures and growing demand for long-term diabetes management solutions. Based on application, the global continuous glucose monitoring system for elderly market can be divided into hospitals & clinics and homecare settings.
Product Definition:
A continuous glucose monitoring system for elderly is a device that monitors the blood sugar levels of an elderly person continuously. This device helps to ensure that the blood sugar levels of the elderly person are within a safe range and also helps to prevent any dangerous drops or spikes in blood sugar levels.
Wearable:
The global wearable market is expected to witness significant growth over the forecast period. The major driving factors for this market are increasing geriatric population, rising health awareness and technological advancements in sensor technology. Moreover, decreasing healthcare costs and improved quality of life due to these devices is also a key factor propelling the wearables industry.
Implantable:
Implantable CGM devices are small glucose sensors that are surgically placed inside the body. These sensors can wirelessly communicate with a monitor device which is usually worn on the wrist. The data obtained from these monitors is used to provide information regarding blood sugar levels in individuals suffering from diabetes and other related health conditions such as cardiovascular diseases, neurovascular disorders, etc.
Application Insights:
The hospital and clinic settings segment dominated the global market in 2017. This is owing to factors such as rising geriatric population, increasing prevalence of diabetes, and an increase in the number of hospitals and clinics across various regions. For instance, as per WHO estimates for 2016, there are approximately 462 million people aged 60 years or above globally; out of which 156 million live in Europe. Furthermore, according to a study published by NCBI in 2018 regarding diabetes type-specific incidence rate by age group shows that among different age groups (0-19 years), type 1 diabetes accounts for highest incidence rate followed by Type 2 diabetes mellitus. Therefore, an increase in the prevalence of diseases coupled with growing aging population globally may drive demand for CGM systems at hospital and clinic settings over the forecast period.
Homecare settings include assisted living facilities (ALFs) or residential care homes (RCH).
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to increasing prevalence of diabetes and obesity, rising adoption of CGM systems by patients, healthcare providers, and payers as well as technological advancements associated with these systems. Moreover, presence of key players such as Abbott Laboratories; Medtronic; Novo Nordisk A/S; Roche Diabetes Care GmbH & Co., Ltd.; and Johnson & Johnson Services Inc.; in this region is also expected to drive the growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to factors such as improving economic status resulting in increased disposable income coupled with growing aging population that requires continuous glucose monitoring system for effective management of diabetes complications along with supportive government initiatives for disease prevention.
Growth Factors:
- Increasing prevalence of diabetes in elderly population
- Rising awareness about the benefits of continuous glucose monitoring system for elderly
- Technological advancements in continuous glucose monitoring system for elderly
- Growing demand for home-based healthcare services
- Increasing number of private and government initiatives to support research and development activities for continuous glucose monitoring system for elderly
Scope Of The Report
Report Attributes
Report Details
Report Title
Continuous Glucose Monitoring System for Elderly Market Research Report
By Type
Wearable, Implantable
By Application
Hospitals & Clinics, Homecare Settings
By Companies
Abbott Diabetes Care Inc., Dexcom, Medtronic, Senseonics Holdings, GlySens Incorporated, Meiqi Medical Equipment, San Meditech
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
225
Number of Tables & Figures
158
Customization Available
Yes, the report can be customized as per your need.
Global Continuous Glucose Monitoring System for Elderly Market Report Segments:
The global Continuous Glucose Monitoring System for Elderly market is segmented on the basis of:
Types
Wearable, Implantable
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals & Clinics, Homecare Settings
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Abbott Diabetes Care Inc.
- Dexcom
- Medtronic
- Senseonics Holdings
- GlySens Incorporated
- Meiqi Medical Equipment
- San Meditech
Highlights of The Continuous Glucose Monitoring System for Elderly Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Wearable
- Implantable
- By Application:
- Hospitals & Clinics
- Homecare Settings
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Continuous Glucose Monitoring System for Elderly Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A Continuous Glucose Monitoring System for Elderly (CGM) is a medical device that continuously monitors blood glucose levels in people with diabetes. CGM can help people with diabetes manage their blood sugar levels more effectively by providing real-time information about how well their insulin is working and how much sugar is in their blood.
Some of the key players operating in the continuous glucose monitoring system for elderly market are Abbott Diabetes Care Inc., Dexcom, Medtronic, Senseonics Holdings, GlySens Incorporated, Meiqi Medical Equipment, San Meditech.
The continuous glucose monitoring system for elderly market is expected to register a CAGR of 7.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Continuous Glucose Monitoring System for Elderly Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Continuous Glucose Monitoring System for Elderly Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Continuous Glucose Monitoring System for Elderly Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Continuous Glucose Monitoring System for Elderly Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Continuous Glucose Monitoring System for Elderly Market Size & Forecast, 2018-2028
4.5.1 Continuous Glucose Monitoring System for Elderly Market Size and Y-o-Y Growth
4.5.2 Continuous Glucose Monitoring System for Elderly Market Absolute $ Opportunity
Chapter 5 Global Continuous Glucose Monitoring System for Elderly Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Continuous Glucose Monitoring System for Elderly Market Size Forecast by Type
5.2.1 Wearable
5.2.2 Implantable
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Continuous Glucose Monitoring System for Elderly Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Continuous Glucose Monitoring System for Elderly Market Size Forecast by Applications
6.2.1 Hospitals & Clinics
6.2.2 Homecare Settings
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Continuous Glucose Monitoring System for Elderly Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Continuous Glucose Monitoring System for Elderly Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Continuous Glucose Monitoring System for Elderly Analysis and Forecast
9.1 Introduction
9.2 North America Continuous Glucose Monitoring System for Elderly Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Continuous Glucose Monitoring System for Elderly Market Size Forecast by Type
9.6.1 Wearable
9.6.2 Implantable
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Continuous Glucose Monitoring System for Elderly Market Size Forecast by Applications
9.10.1 Hospitals & Clinics
9.10.2 Homecare Settings
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Continuous Glucose Monitoring System for Elderly Analysis and Forecast
10.1 Introduction
10.2 Europe Continuous Glucose Monitoring System for Elderly Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Continuous Glucose Monitoring System for Elderly Market Size Forecast by Type
10.6.1 Wearable
10.6.2 Implantable
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Continuous Glucose Monitoring System for Elderly Market Size Forecast by Applications
10.10.1 Hospitals & Clinics
10.10.2 Homecare Settings
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Continuous Glucose Monitoring System for Elderly Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Continuous Glucose Monitoring System for Elderly Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Continuous Glucose Monitoring System for Elderly Market Size Forecast by Type
11.6.1 Wearable
11.6.2 Implantable
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Continuous Glucose Monitoring System for Elderly Market Size Forecast by Applications
11.10.1 Hospitals & Clinics
11.10.2 Homecare Settings
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Continuous Glucose Monitoring System for Elderly Analysis and Forecast
12.1 Introduction
12.2 Latin America Continuous Glucose Monitoring System for Elderly Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Continuous Glucose Monitoring System for Elderly Market Size Forecast by Type
12.6.1 Wearable
12.6.2 Implantable
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Continuous Glucose Monitoring System for Elderly Market Size Forecast by Applications
12.10.1 Hospitals & Clinics
12.10.2 Homecare Settings
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Continuous Glucose Monitoring System for Elderly Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Continuous Glucose Monitoring System for Elderly Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Continuous Glucose Monitoring System for Elderly Market Size Forecast by Type
13.6.1 Wearable
13.6.2 Implantable
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Continuous Glucose Monitoring System for Elderly Market Size Forecast by Applications
13.10.1 Hospitals & Clinics
13.10.2 Homecare Settings
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Continuous Glucose Monitoring System for Elderly Market: Competitive Dashboard
14.2 Global Continuous Glucose Monitoring System for Elderly Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Abbott Diabetes Care Inc.
14.3.2 Dexcom
14.3.3 Medtronic
14.3.4 Senseonics Holdings
14.3.5 GlySens Incorporated
14.3.6 Meiqi Medical Equipment
14.3.7 San Meditech
